Abstract
The recent paper by Dudley et al. (1) entitled “Detection and surveillance of bladder cancer using urine tumor DNA” adds to the burgeoning evidence that massively-parallel sequencing of urinary DNA reliably detects tumour-associated mutations in urinary DNA. This approach promises to resolve the long overdue need for a sensitive and specific non-invasive test for bladder cancer. In this editorial we discuss the existing body of evidence and what the study by Dudley et al. contributes to this rapidly-evolving field of cancer research.
Original language | English |
---|---|
Pages (from-to) | S204-S207 |
Number of pages | 4 |
Journal | Translational Cancer Research |
Volume | 8 |
Issue number | Suppl 2 |
Early online date | 4 Mar 2019 |
DOIs | |
Publication status | Published - 31 Mar 2019 |
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research